Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J7686
    Short Description Treprostinil, non-comp unit
    Long Description Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
    Pricing indicator 51
    Coverage code C
    ASC payment group code
    BETOS2 code D1G
    Action code N
    Type of service 1
    Effective date 2011-01-01
    Date Added 2011-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    66302020601 J7686 Treprostinil, non-comp unit TYVASO (Starter Kit) UNITED THERAPEUTICS 1.74 MG 2.9 28 1 28
    66302020602 J7686 Treprostinil, non-comp unit TYVASO (Refill Kit) UNITED THERAPEUTICS 1.74 MG 2.9 28 1 28
    66302020603 J7686 Treprostinil, non-comp unit TYVASO UNITED THERAPEUTICS 1.74 MG 2.9 4 1 4
    66302020604 J7686 Treprostinil, non-comp unit TYVASO UNITED THERAPEUTICS 1.74 MG 2.9 4 1 4
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 1.74 MG
    HCPCS/CPT Billing Units 1
    Total doses ordered
    Billing Units 1